Paper16642000
Targeting C-reactive protein for the treatment of cardiovascular disease.
Pepys MB and 20 others. Nature, 2006. Cited by 540 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Targeting C-reactive protein for the treatment of cardiovascular disease. Papers, record 16642000. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16642000
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| C-Reactive Protein | Major topic |
| Cardiovascular Diseases | Major topic |
| Hexanes | Major topic |
| Phosphorylcholine | Major topic |
| Animals | |
| Complement System Proteins | |
| Drug Design | |
| Humans | |
| Male | |
| Models, Molecular | |
| Molecular Conformation | |
| Myocardial Infarction | |
| Rats | |
| Rats, Wistar |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| G7900510 | Medical Research Council | United Kingdom | PubMed | |
| Wellcome Trust | United Kingdom | PubMed |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT06263452 | Beta-Blocker Influences on Inflammatory and Neural Responses to Stress | Background |
Source ClinicalTrials.gov
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 16,861,733 | C-reactive protein--does it promote vascular disease? | https://conductscience.org/library/papers/16861733 |
Source PubMed
Cited by246
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 540 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,827,456 | Prognostic value of CALLY index in combination with the GRACE score among patients with acute myocardial infarction: a retrospective cohort study. | Front Cardiovasc Med | 2026 | https://conductscience.org/library/papers/42827456 | PubMed |
| 42,274,591 | CRP (C-Reactive Protein) Revisited: An Old Yet New Biomarker of Acute and Chronic Inflammation. | Cells | 2026 | https://conductscience.org/library/papers/42274591 | PubMed |
| 42,255,886 | Monomeric C-reactive Protein as a Mediator of Chronic Inflammation in Obesity. | Cureus | 2026 | https://conductscience.org/library/papers/42255886 | PubMed |
| 42,075,763 | In Murine Disseminated Candidiasis, Serum Amyloid P Component Inhibits Inflammation and C-Reactive Protein Potentiates Inflammation. | Pathogens | 2026 | https://conductscience.org/library/papers/42075763 | PubMed |
| 42,064,727 | Complement Components C1r and C8 Serve as Potential Inflammatory Biomarkers for Coronary Heart Disease Severity: The Mediating Role of C-Reactive Protein. | J Inflamm Res | 2026 | https://conductscience.org/library/papers/42064727 | PubMed |
| 41,031,135 | An aptamer specifically targeting mCRP ameliorates experimental arthritis. | J Orthop Translat | 2025 | https://conductscience.org/library/papers/41031135 | PubMed |
| 40,946,170 | What impact could tirzepatide have on major cardiovascular complications in patients with obstructive sleep apnea? | Expert Rev Cardiovasc Ther | 2025 | https://conductscience.org/library/papers/40946170 | PubMed |
| 40,943,152 | Beyond the Biomarker: Monomeric CRP as a Driver of Multisystem Pathology in Rheumatoid Arthritis. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40943152 | PubMed |
| 40,679,780 | From Homeostasis To Inflammation To Autoimmunity: The Potential Impact of CRP. | Inflammation | 2025 | https://conductscience.org/library/papers/40679780 | PubMed |
| 40,649,973 | mCRP-Associated Vascular Pathophysiology in Progression and Outcome of Intracerebral Hemorrhage. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40649973 | PubMed |
| 40,618,008 | Identification of Prognostic Factors for Sepsis or Septic Shock Patients with Cardiac Dysfunction. | J Cardiovasc Transl Res | 2025 | https://conductscience.org/library/papers/40618008 | PubMed |
| 40,309,624 | Pre-Percutaneous Coronary Intervention C-Reactive Protein Levels and In-Stent Restenosis: A Systematic Review and Meta-Analysis. | Health Sci Rep | 2025 | https://conductscience.org/library/papers/40309624 | PubMed |
| 40,282,303 | Battle of the Biomarkers of Systemic Inflammation. | Biology (Basel) | 2025 | https://conductscience.org/library/papers/40282303 | PubMed |
| 40,182,153 | Cardioprotective strategies in myocardial ischemia-reperfusion injury: Implications for improving clinical translation. | J Mol Cell Cardiol Plus | 2025 | https://conductscience.org/library/papers/40182153 | PubMed |
| 39,995,674 | Association of high-sensitivity C-reactive protein with hepatic fibrosis in patients with metabolic dysfunction-associated steatotic liver disease. | Front Immunol | 2025 | https://conductscience.org/library/papers/39995674 | PubMed |
| 39,773,175 | A conformational change of C-reactive protein drives neutrophil extracellular trap formation in inflammation. | BMC Biol | 2025 | https://conductscience.org/library/papers/39773175 | PubMed |
| 39,708,799 | C-reactive protein in diabetic kidney disease: A new therapeutic avenue? | Mol Ther | 2025 | https://conductscience.org/library/papers/39708799 | PubMed |
| 39,613,449 | Can high-sensitivity C reactive protein (hsCRP) be used as a prognostic marker of functional disability after acute ischaemic stroke? A cross-sectional study at a tertiary care centre in Eastern India. | BMJ Open | 2024 | https://conductscience.org/library/papers/39613449 | PubMed |
| 39,554,800 | Role of C-reactive protein in disease progression, diagnosis and management. | Discoveries (Craiova) | 2023 | https://conductscience.org/library/papers/39554800 | PubMed |
| 39,553,311 | Association of Uric Acid, High-Sensitivity C-Reactive Protein, and 90-Day Risk of Poor Function Outcome in Patients with Ischemic Stroke or Transient Ischemic Attacks. | J Inflamm Res | 2024 | https://conductscience.org/library/papers/39553311 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CRP | 1,401 | PubTator's text mining | https://conductscience.org/library/genes/1401 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/16642000
GET https://conductscience.org/api/papers/v1/16642000/authors?page=2